Science
- Volume 375
- Issue 6576
- 7 Jan 2022
COVER Lipid nanoparticles (spheres) use antibodies against the CD5 protein (antibodies, blue; CD5, red) to specifically target T cells while inside the bloodstream and tissues. The nanoparticles deliver mRNA to T cells, reprogramming them in vivo to transiently express chimeric antigen receptors (gold) that target pathogenic cardiac fibroblasts. In vivo–engineered T cells mitigate cardiac fibrosis and improve heart function in a mouse model. See pages 23 and 91.
Illustration: C. Bickel/Science
Research ArticlesBy
- N. Gjorevski
- M. Nikolaev
- et al.
Tissue geometry drives deterministic organoid patterning
ReportsBy
- Nikola Maksimovic
- Daniel H. Eilbott
- et al.
Evidence for a delocalization quantum phase transition without symmetry breaking in CeCoIn5
ReportsBy
- Beate Kraft
- Nico Jehmlich
- et al.
Oxygen and nitrogen production by an ammonia-oxidizing archaeon
ReviewsBy
- Ton N. Schumacher
- Daniela S. Thommen
- et al.
Tertiary lymphoid structures in cancer
Advertisement
News
Editorial
11 Jan 2022
Strengthening scientific integrity
6 Jan 2022
Lessons learned from leading NIH
First Release
ABOUT
Science is a leading outlet for scientific news, commentary, and cutting-edge research. Through its print and online incarnations, Science reaches an estimated worldwide readership of more than one million. Science’s authorship is global too, and its articles consistently rank among the world's most cited research.
